कोशिश गोल्ड - मुक्त

China’s K visa faces a backlash: It made its debut at a bad time

Mint Kolkata

|

October 15, 2025

Local job-seekers are worried about the tech sector’s hiring slump

- JULIANA LIU

China’s K visa faces a backlash: It made its debut at a bad time

You might have thought Beijing’s effort to attract global STEM talent would fire up legions of patriotic keyboard warriors eager to celebrate America’s relative decline. Instead, its launch of a new work visa has sparked an online furore, highlighting the underbelly of China’s much-vaunted industrial policy.

The decade-long ‘Made in China’ campaign to ensure the country can compete with the best of the West in 10 key industries including robotics, electric vehicles and pharmaceuticals—has been largely successful. Technical prowess, exemplified by January's DeepSeek moment, has fired up China’s stock market. But it’s not been enough to fill the gap left by the collapse of its property sector, which once accounted for as much as 32% of the economy.

Consumer pessimism was on display last week when the country wrapped up an eight-day holiday break. Fresh data suggest travellers were pinching their pennies. Spending was subdued, road trips replaced flights and box-office sales missed expectations, according to Bloomberg News.

Against this backdrop, it wasn't an ideal time to debut the K visa—what some have called China’s equivalent of America’s H-IB. Its details are scant, though it comes as part of Beijing’s post-pandemic moves to loosen restrictions on dozens of countries to revitalize travel and consumption.

Mint Kolkata से और कहानियाँ

Mint Kolkata

Why ₹1-tn unclaimed wealth is still out of investors’ reach

Unclaimed assets include deposits, insurance payouts, mutual funds, dividends and shares

time to read

4 mins

October 15, 2025

Mint Kolkata

Neither lawyers nor engineers run India and that’s fine

In his book, Breakneck: China’s Quest to Engineer the Future, Dan Wang describes two distinct approaches to development.

time to read

3 mins

October 15, 2025

Mint Kolkata

Mint Kolkata

Bira's backers discuss fund infusion, CEO's exit

have petitioned B9's board and investors citing delayed salaries and governance concerns, The Economic Times reported last Thursday.

time to read

3 mins

October 15, 2025

Mint Kolkata

Mint Kolkata

TV old guards bet on short-video boom

As TV suffers a slow decline and audiences rush to dopamine-fuelled shortspan entertainment, makers of hit soap operas that dominated Indian entertainment are turning to microdramas and other short video and audio formats.

time to read

2 mins

October 15, 2025

Mint Kolkata

Mint Kolkata

DMart Ready in metros after q-comm trips it in small cities

Avenue Supermarts Ltd, which runs the DMart retail chain, exited its DMart Ready order-and-pickup operations in five cities in the July-September quarter, signalling continuing pressure from quick commerce companies and a pivot towards metro markets with stronger digital demand for groceries.

time to read

2 mins

October 15, 2025

Mint Kolkata

Mint Kolkata

'Tesla scheme' may continue as India’s EV chase sputters

In June, the Centre notified guidelines for the scheme and opened the investment window

time to read

2 mins

October 15, 2025

Mint Kolkata

A reality check on Diwali stock picks

The annual rush of ‘Diwali picks’ is here, with brokerages promising to light up your portfolio like a firecracker. But before you load upon their “shubh labh” (auspicious profit) stocks, remember that the gains are not certain.

time to read

2 mins

October 15, 2025

Mint Kolkata

China escalates US trade fight with curbs on shipping

China sanctioned the US units of a South Korean shipping giant and threatened further retaliatory measures on the industry, the latest in a series of tit-for-tat moves as Beijing and Wash-

time to read

1 min

October 15, 2025

Mint Kolkata

Mint Kolkata

Roche moves SC against Natco over Risdiplam sale in India

Swiss drugmaker Roche has moved the Supreme Court, seeking to restrain Natco Pharma from selling the generic version of its lifesaving spinal muscular atrophy (SMA) drug Risdiplam in India.

time to read

1 mins

October 15, 2025

Mint Kolkata

Mint Kolkata

Can algos make music with soul? Prasar Bharati bets on an AI rock band

Are the days of musicians, vocalists, and lyricists numbered?

time to read

2 mins

October 15, 2025

Listen

Translate

Share

-
+

Change font size